nach oben

Cardiovascular Intervention and Therapeutics

Erschienen in:

15.03.2016 | Case Report

A case of subacute stent thrombosis after drug-coated balloon coronary angioplasty for in-stent restenosis under single anti-platelet therapy

verfasst von: Yuzo Kagawa, Nobuo Shiode, Tomoharu Kawase, Hiromichi Tamekiyo, Tomokazu Okimoto, Yasuhiko Hayashi

Erschienen in: Cardiovascular Intervention and Therapeutics | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

This report describes a case of subacute stent thrombosis (SAT) after drug-coated balloon (DCB). A 79-year-old male was investigated for stable angina. An in-stent restenosis (ISR) lesion was detected by coronary angiography. A skin reaction related to the anti-platelet agent thienopyridine was also observed at this time. Therefore, DCB was used to treat the ISR lesion under single anti-platelet therapy (aspirin). However, 3 days after percutaneous coronary intervention, SAT occurred. OCT did not reveal the underlying cause of SAT. Further data are needed to clarify the optimal duration of dual anti-platelet therapy after DCB.

Scheller B, Clever YP, Kelsch B, Hehrlein C, Bocksch W, et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. JACC Cardiovasc Interv. 2012;5(3):323–30.CrossRefPubMed

Rittger H, Brachmann J, Sinha AM, Waliszewski M, Ohlow M, et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol. 2012;59(15):1377–82.CrossRefPubMed

Habara S, Mitsudo K, Kadota K, Goto T, Fujii S, et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc Interv. 2011;4(2):149–54.CrossRefPubMed

Kolh P, Windecker S, Alfonso F, Collet JP, Cremer J, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cariothorac Surg. 2014;46(4):517–92.CrossRef

Joner M, Byrne RA, Lapointe JM, Radke PW, Bayer G, Steigerwald K, et al. Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis. Thromb Haemost. 2011;105:864–72.CrossRefPubMed

Gao S, Sheb J, Mukku VK, Wang MJ, Akhtar M, et al. Efficacy of drug-eluting balloons for patients with in-stent restenosis: a meta-analysis of 8 randomized controlled trials. Angiology. 2015;0003319715611826.

Zeymer U, Waliszewski M, Spiecker M, Gastmann O, Faurie B, Ferrari M, et al. Prospective ‘real world’ registry for the use of the ‘PCB only’ strategy in small vessel de novo lesions. Heart. 2014;100:311–6.CrossRefPubMed

Edouard C, Laurent L, Gary SM, Jun-ichi Augusto DP, Lowell FS, et al. Predictors of subacute stent thrombosis results of a systematic intravascular ultrasound study. Circulation. 2003;108:43–7.CrossRef

Stähli BE, Camici GG, Steffel J, Akhmedov A, Shojaati K, et al. Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation. Circ Res. 2006;99(2):149–55.CrossRefPubMed

10.

Zhang S, Sun C, Hu H, He Y, Yao Y et al. Effects of paclitaxel on the ability of aspirin and clopidogrel to inhibit platelet aggregation. Clin Appl Thromb Hemost. 2015;1076029615576740.

11.

Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, et al. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet. 2013;381(9865):461–7.CrossRefPubMed

12.

Tannenbaum SH, Finko R, Cines DB. Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol. 1986;137:1532–7.PubMed

Titel: A case of subacute stent thrombosis after drug-coated balloon coronary angioplasty for in-stent restenosis under single anti-platelet therapy
verfasst von: Yuzo Kagawa
Nobuo Shiode
Tomoharu Kawase
Hiromichi Tamekiyo
Tomokazu Okimoto
Yasuhiko Hayashi
Publikationsdatum: 15.03.2016
Verlag: Springer Japan
Erschienen in: Cardiovascular Intervention and Therapeutics / Ausgabe 2/2017
Print ISSN: 1868-4300
Elektronische ISSN: 1868-4297
DOI: https://doi.org/10.1007/s12928-016-0386-0

Neu im Fachgebiet Kardiologie

25.04.2024 | Hypotonie | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

A case of subacute stent thrombosis after drug-coated balloon coronary angioplasty for in-stent restenosis under single anti-platelet therapy

Abstract

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2017

Judkins right guiding catheter bailed out acute aortic insufficiency during balloon aortic valvuloplasty

Risk of bleeding and repeated bleeding events in prasugrel-treated patients: a review of data from the Japanese PRASFIT studies

Transradial intervention for chronic total occlusion at the external iliac artery using a bidirectional approach through a single guiding catheter

Usefulness of rotational atherectomy with optical frequency domain imaging guidance for severe calcified coronary lesions after Kawasaki disease

Life- and limb-saving endovascular therapy in a patient with acute abdominal aortic occlusion

Lesion characteristics of coronary arteries associated with a mismatch between angiographic severity of stenosis and fractional flow reserve

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie